![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 11, 7481-7491, March 17, 2000
From the Department of Biomolecular Chemistry and Endocrinology and
Reproductive Physiology Program, University of Wisconsin,
Madison, Wisconsin 53706-1532
Caveolin-1 is the major coat protein
of caveolae and has been reported to interact with various
intracellular signaling molecules including the epidermal growth factor
(EGF) receptor. To investigate the involvement of caveolin-1 in EGF
receptor action, we used mouse B82L fibroblasts transfected with
(a) wild type EGF receptor, (b) a C-terminally
truncated EGF receptor at residue 1022, (c) a C-terminally
truncated EGF receptor at residue 973, or (d) a kinase-inactive EGF receptor (K721M). Following EGF treatment, there
was a distinct electrophoretic mobility shift of the caveolin-1 present
in cells expressing the truncated forms of the EGF receptor, but this
shift was not detectable in cells bearing either normal levels of the
wild type EGF receptor or a kinase-inactive receptor. This mobility
shift was also not observed following the addition of other cell
stimuli, such as platelet-derived growth factor, insulin, basic
fibroblast growth factor, or phorbol 12-myristate 13-acetate. Analysis
of caveolin-1 immunoprecipitates from EGF-stimulated or nonstimulated
cells demonstrated that the EGF-induced mobility shift of caveolin-1
was associated with its tyrosine phosphorylation in cells expressing
truncated EGF receptors. Maximal caveolin-1 phosphorylation was
achieved within 5 min after exposure to 10 nM EGF and
remained elevated for at least 2 h. Additionally, several distinct
phosphotyrosine-containing proteins (60, 45, 29, 24, and 20 kDa) were
co-immunoprecipitated with caveolin-1 in an EGF-dependent manner. Furthermore, the Src family kinase inhibitor, PP1, does not
affect autophosphorylation of the receptor, but it does inhibit the
EGF-induced mobility shift and phosphorylation of caveolin-1. Conversely, the MEK inhibitors PD98059 and UO126 could attenuate EGF-induced mitogen-activated protein kinase activation, they do not
affect the EGF-induced mobility shift of caveolin-1. Because truncation
and overexpression of the EGF receptor have been linked to cell
transformation, these results provide the first evidence that the
tyrosine phosphorylation of caveolin-1 occurs via an EGF-sensitive
signaling pathway that can be potentiated by an aberrant activity or
expression of various forms of the EGF receptor.
Epidermal Growth Factor-stimulated Tyrosine Phosphorylation of
Caveolin-1
ENHANCED CAVEOLIN-1 TYROSINE PHOSPHORYLATION FOLLOWING
ABERRANT EPIDERMAL GROWTH FACTOR RECEPTOR STATUS*
*
This work was funded by National Institutes of Health Grant
R01 GM53271 (to P. J. B.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Biomolecular
Chemistry and Endocrinology and Reproductive Physiology Program,
University of Wisconsin, 1300 University Ave., Madison, WI 53706-1532. Tel.: 608-262-8667; Fax: 608-262-5253; E-mail: pbertics@macc.wisc.edu.
This article has been cited by other articles:
![]() |
F. Peng, B. Zhang, D. Wu, A. J. Ingram, B. Gao, and J. C. Krepinsky TGF{beta}-induced RhoA activation and fibronectin production in mesangial cells require caveolae Am J Physiol Renal Physiol, July 1, 2008; 295(1): F153 - F164. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Evseenko, J. W. Paxton, and J. A. Keelan Independent Regulation of Apical and Basolateral Drug Transporter Expression and Function in Placental Trophoblasts by Cytokines, Steroids, and Growth Factors Drug Metab. Dispos., April 1, 2007; 35(4): 595 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Peng, D. Wu, A. J. Ingram, B. Zhang, B. Gao, and J. C. Krepinsky RhoA Activation in Mesangial Cells by Mechanical Strain Depends on Caveolae and Caveolin-1 Interaction J. Am. Soc. Nephrol., January 1, 2007; 18(1): 189 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Vihanto, C. Vindis, V. Djonov, D. P. Cerretti, and U. Huynh-Do Caveolin-1 is required for signaling and membrane targeting of EphB1 receptor tyrosine kinase J. Cell Sci., June 1, 2006; 119(11): 2299 - 2309. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. C. Li, M. J. Park, S.-K. Ye, C.-W. Kim, and Y.-N. Kim Elevated Levels of Cholesterol-Rich Lipid Rafts in Cancer Cells Are Correlated with Apoptosis Sensitivity Induced by Cholesterol-Depleting Agents Am. J. Pathol., April 1, 2006; 168(4): 1107 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ushio-Fukai, L. Zuo, S. Ikeda, T. Tojo, N. A. Patrushev, and R. W. Alexander cAbl Tyrosine Kinase Mediates Reactive Oxygen Species- and Caveolin-Dependent AT1 Receptor Signaling in Vascular Smooth Muscle: Role in Vascular Hypertrophy Circ. Res., October 14, 2005; 97(8): 829 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-b. Chen, S.-m. Li, X.-X. Qian, C. Moon, and J. Zheng Tyrosine Phosphorylation of Caveolin 1 by Oxidative Stress Is Reversible and Dependent on the c-src Tyrosine Kinase but Not Mitogen-Activated Protein Kinase Pathways in Placental Artery Endothelial Cells Biol Reprod, October 1, 2005; 73(4): 761 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ikeda, M. Ushio-Fukai, L. Zuo, T. Tojo, S. Dikalov, N. A. Patrushev, and R. W. Alexander Novel Role of ARF6 in Vascular Endothelial Growth Factor-Induced Signaling and Angiogenesis Circ. Res., March 4, 2005; 96(4): 467 - 475. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Labrecque, C. Nyalendo, S. Langlois, Y. Durocher, C. Roghi, G. Murphy, D. Gingras, and R. Beliveau Src-mediated Tyrosine Phosphorylation of Caveolin-1 Induces Its Association with Membrane Type 1 Matrix Metalloproteinase J. Biol. Chem., December 10, 2004; 279(50): 52132 - 52140. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Beebe, G. J. Wiepz, A. G. Guadarrama, P. J. Bertics, and T. J. Burke A Carboxyl-terminal Mutation of the Epidermal Growth Factor Receptor Alters Tyrosine Kinase Activity and Substrate Specificity as Measured by a Fluorescence Polarization Assay J. Biol. Chem., July 11, 2003; 278(29): 26810 - 26816. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Labrecque, I. Royal, D. S. Surprenant, C. Patterson, D. Gingras, and R. Beliveau Regulation of Vascular Endothelial Growth Factor Receptor-2 Activity by Caveolin-1 and Plasma Membrane Cholesterol Mol. Biol. Cell, January 1, 2003; 14(1): 334 - 347. [Abstract] [Full Text] |
||||
![]() |
X.-Q. Wang, P. Sun, and A. S. Paller Ganglioside Induces Caveolin-1 Redistribution and Interaction with the Epidermal Growth Factor Receptor J. Biol. Chem., November 27, 2002; 277(49): 47028 - 47034. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lee, D. S. Park, X. B. Wang, P. E. Scherer, P. E. Schwartz, and M. P. Lisanti Src-induced Phosphorylation of Caveolin-2 on Tyrosine 19. PHOSPHO-CAVEOLIN-2 (TYR(P)19) IS LOCALIZED NEAR FOCAL ADHESIONS, REMAINS ASSOCIATED WITH LIPID RAFTS/CAVEOLAE, BUT NO LONGER FORMS A HIGH MOLECULAR MASS HETERO-OLIGOMER WITH CAVEOLIN-1 J. Biol. Chem., September 6, 2002; 277(37): 34556 - 34567. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wu, L. M. Graves, G. N. Gill, S. J. Parsons, and J. M. Samet Src-dependent Phosphorylation of the Epidermal Growth Factor Receptor on Tyrosine 845 Is Required for Zinc-induced Ras Activation J. Biol. Chem., June 28, 2002; 277(27): 24252 - 24257. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-N. Kim and P. J. Bertics The Endocytosis-Linked Protein Dynamin Associates with Caveolin-1 and Is Tyrosine Phosphorylated in Response to the Activation of a Noninternalizing Epidermal Growth Factor Receptor Mutant Endocrinology, May 1, 2002; 143(5): 1726 - 1731. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Vargas, B. F. Nore, A. Berglof, J. E. Heinonen, P. T. Mattsson, C. I. E. Smith, and A. J. Mohamed Functional Interaction of Caveolin-1 with Bruton's Tyrosine Kinase and Bmx J. Biol. Chem., March 8, 2002; 277(11): 9351 - 9357. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Coller and D. M. Paulnock Signaling pathways initiated in macrophages after engagement of type A scavenger receptors J. Leukoc. Biol., July 1, 2001; 70(1): 142 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Watters, T.-Y. Chun, Y.-N. Kim, P. J. Bertics, and J. Gorski Estrogen Modulation of Prolactin Gene Expression Requires an Intact Mitogen-Activated Protein Kinase Signal Transduction Pathway in Cultured Rat Pituitary Cells Mol. Endocrinol., November 1, 2000; 14(11): 1872 - 1881. [Abstract] [Full Text] |
||||
![]() |
A. Caselli, M. L. Taddei, G. Manao, G. Camici, and G. Ramponi Tyrosine-phosphorylated Caveolin Is a Physiological Substrate of the Low Mr Protein-Tyrosine Phosphatase J. Biol. Chem., May 25, 2001; 276(22): 18849 - 18854. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |